Notice Regarding Changes in Subsidiaries (Conversion of Non-Consolidated Subsidiary to Consolidated Subsidiary) and Management Structure
NQ Score
50/100
AI Summary (NQ-processed)
Alfresa Holdings converts its non-consolidated subsidiary ArkMS into a consolidated subsidiary to strengthen its TSCS strategy.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the purpose of consolidating ArkMS?
- A: It is to strengthen the group's Total Supply Chain Service (TSCS) strategy, as the importance of drug development support has increased.
- Q: When is the effective date of the change?
- A: April 1, 2026.
- Q: How will this reorganization affect the industry?
- A: By internalizing development support functions, pharmaceutical wholesalers can enhance their comprehensive service capabilities for pharmaceutical companies.